Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: Relevance to Alzheimer disease and vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 3-4, 2004, Pages 265-270

  Polidori, M Cristina ^a   Mattioli, Paola ^b   Aldred, Sarah ^c   Cecchetti, Roberta ^b   Stahl, Wilhelm ^a   Griffiths, Helen ^c   Senin, Umberto ^b   Sies, Helmut ^a   Mecocci, Patrizia ^b,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ASTON UNIVERSITY   (United Kingdom)

^d POLICLINICO MONTELUCE   (Italy)

Author keywords

Alzheimer disease; Antioxidants; Oxidative stress; Vascular dementia

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CAROTENOID; CRYPTOXANTHIN; IMMUNOGLOBULIN G; LYCOPENE; MALONALDEHYDE; RETINOL; TRACE ELEMENT; TYROSINE; URIC ACID; WATER; XANTHOPHYLL; ZEAXANTHIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; LIPID PEROXIDATION; LIPOPHILICITY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; OXIDATION; PLASMA; PRIORITY JOURNAL; SOLUBILITY; STATISTICAL SIGNIFICANCE;

AGED; ALZHEIMER DISEASE; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEMENTIA, VASCULAR; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; VITAMINS;

EID: 5644239560     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080027     Document Type: Article

References (57)

1. Ojaimi J, Byrne E: Mitochondrial function and Alzheimer's disease. Biol Signals Recept 2001;10:254-262.
2. Sies H, Stahl W, Polidori MC: Oxidative stress: Antioxidants in degenerative neurological and ophthalmological disorders; in Bachmann C, Koletzko E (eds): Genetic Expression and Nutrition. Nestlé Nutrition Workshop Series. Philadelphia, Lippincott Williams & Wilkins, 2003, vol 50, pp 107-118.
3. Beal MF: Mitochondria and oxidative damage in amyotrophic lateral sclerosis. Funct Neurol 2001;16:161-169.
4. Rego AC, Oliveira CR: Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 2003;28:1563-1574.
5. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schüssel K, Müller WE: Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 2003;66:1627-1634.
6. Markesbery WR, Carney JM: Oxidative alterations in Alzheimer's disease. Brain Pathol 1999;9:133-146.
7. Mecocci P, MacGarvey U, Beal MF: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-751.
8. Mecocci P, Polidori MC, Ingegni T, Cherubini A, Chionne F, Cecchetti R, Senin U: Oxidative damage to DNA in lymphocytes from AD patients. Neurology 1998;51:1014-1017.
9. Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, Rinaldi P, Cecchetti R, Stahl W, Senin U, Beal MF: Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002;59:794-798.
10. Perrig WJ, Perrig P, Stahelin HB: The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997;45:718-724.
11. Jimenéz-Jimenéz FJ, Molina JA, de Bustos F, Orti-Pareja M, Benito-Leon J, Tallon-Barranco A, Gasalla T, Porta J, Arenas J: Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. Eur J Neurol 1999;6:495-497.
12. Rivière S, Birlouez-Aragon I, Nourhashemi F, Vellas B: Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 1998;13:749-754.
13. Jimenéz-Jimenéz FJ, de Bustos F, Molina JA, Benito-Leon J, Tallon-Barranco A, Gasalla T, Orti-Pareja M, Guillamon F, Rubio JC, Arenas J, Enriquez-de-Salamanca R: Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J Neural Transm 1997;104:703-710.
14. Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H: Profiles of antioxidants in human plasma. Free Radic Biol Med 2001;30:456-462.
15. Mecocci P, Polidori MC, Troiano L, Cherubini A, Cecchetti R, Pini G, Straatman M, Monti D, Stahl W, Sies H, Franceschi C, Senin U: Plasma antioxidants and longevity: A study on healthy centenarians. Free Radic Biol Med 2000;28:1243-1248.
16. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P: Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: Relationship to early outcome. Free Radic Res 2002;36:265-268.
17. Polidori MC, Savino K, Alunni G, Stahl W, Freddio M, Senin U, Sies H, Mecocci P: Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: Relationship to disease severity. Free Radic Biol Med 2002;32:148-152.
18. Polidori MC, Cherubini A, Marvardi M, Senin U, Mecocci P: Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer's dementia. Aging Clin Exp Res 2001;13:231-239.
19. Lin B, Schmidt-Kastner R, Busto R, Ginsberg MD: Progressive parenchymal deposition of beta-amyloid precursor protein in rat brain following global cerebral ischemia. Acta Neuropathol (Berl) 1999;97:359-368.
20. Shi J, Yang SH, Stubley L, Day AL, Simpkins JW: Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000;853:1-4.
21. McCaddon A, Hudson P, Hill D, Barber J, Lloyd A, Davies G, Regland B: Alzheimer's disease and total plasma aminothiols. Biol Psychiatry 2003;53:254-260.
22. Carty JL, Bevan R, Waller H, Mistry N, Cooke M, Lunec J, Griffiths HR: The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 2000;273:729-735.
23. Griffiths HR: The influence of diet on protein oxidation. Nutr Res Rev 2002;15:3-17.
24. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
26. Winkler G, Döring A: Validation of a short qualitative frequency list used in several German large scale surveys. Eur J Nutr 1998;37:234-241.
27. Guigoz Y, Vellas B: The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: Presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme 1999;1:3-11.
28. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-54.
29. Sheikh JI, Yesavage JA: Geriatric Depression Scale: Recent evidence and development of a shorter version; in Brinf TL (ed): Clinical Gerontology: A Guide to Assessment and Intervention. New York, Haworth Press, 1986.
30. Kutnink MA, Hawkes WC, Schaus EE, Omaye ST: An internal standard method for the unattended high-performance liquid analysis of ascorbic acid in blood components. Anal Biochem 1987;166:424-430.
31. Nierenberg DW, Nann SL: A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr 1992;56:417-426.
32. Stahl W, Sundquist AR, Hanusch M, Schwarz W, Sies H: Separation of β-carotene and lycopene geometrical isomers in biological samples. Clin Chem 1993;39:810-814.
33. Griffiths HR, Lunec J, Blake DR: Oxygen radical induced fluorescence in proteins; Identification of the fluorescent tryptophan metabolite, N-formyl kynurenine, as a biological index of radical damage. Amino Acids 1992;3:183-194.
34. Lepage G, Gabriel M, Champagne J, Roy CC: Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem 1991;197:227-282.
35. Vagnucci AH Jr, Li WW: Alzheimer's disease and angiogenesis. Lancet 2003;361:605-608.
36. De La Torre JC: Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Rev 1994;18:397-401.
37. De La Torre JC: Alzheimer's disease: how does it start? J Alzheimers Dis 2002;4:497-512.
38. Jellinger KA, Mitter-Ferstl E: The impact of cerebrovascular lesions in Alzheimer disease - A comparative autopsy study. J Neurol 2003;250:1050-1055.
39. Polidori MC: Oxidative stress and risk factors for Alzheimer's disease: Clues to prevention and therapy. J Alzheimers Dis 2004;6:185-191.
40. Praticò D, Clark CM, Liun F, Lee VY, Trojanowski JQ: Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Arch Neurol 2002;59:972-976.
41. Praticò D, Uryu K, Leight S, Trojanoswki JQ, Lee VM: Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001;21:4183-4187.
42. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
43. Rinaldi P, Polidori MC, Metastasio A, Cherubini A, Cecchetti R, Senin U, Mecocci P: Plasma antioxidants are similarly depleted in mild cognitive impairment and Alzheimer disease. Neurobiol Aging 2003;24:915-919.
44. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M: Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001;30:235-241.
45. Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM: Nutritional factors in cerebral aging and dementia: Epidemiological arguments for a role of oxidative stress. Neuroepidemiology 2001;20:7-15.
46. Youdim KA, Joseph JA: A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: A multiplicity of effects. Free Radic Biol Med 2001;30:583-594.
47. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM: Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002;287:3223-3229.
48. Berger T, Polidori MC, Dabbagh A, Evans P, Halliwell B, Morrow J, Roberts LJ 2nd, Frei B: Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 1997;272:15656-15660.
49. Cuajungco MP, Faget KY, Huang X, Tanzi RE, Bush AI: Metal chelation as a potential therapy for Alzheimer's disease. Ann NY Acad Sci 2000;920:292-304.
50. Ortega RM, Requejo AM, Lopez-Sobaler AM, Andres P, Navia B, Perea JM, Robles F: Cognitive function in elderly people is affected by vitamin E status. J Nutr 2002;132:2065-2068.
51. Di Mascio P, Kaiser S, Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-538.
52. den Heijer T, Launer LJ, de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Breteler MM: Serum carotenoids and cerebral white matter lesions: The Rotterdam Scan Study. J Am Geriatr Soc 2001;49:642-646.
53. Butterfield DA, Kanski J: Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 2001;122:945-962.
54. Conrad CC, Marshall PL, Talent JM, Malakowsky CA, Choi J, Gracy RW: Oxidized proteins in Alzheimer's plasma. Biochem Biophys Res Commun 2000;275:678-681.
55. Kato Y, Mauyama W, Naoi M, Hashizume Y, Osawa T: Immunohistochemical detection of dityrosine in lipofuscin pigments in the aged human brain. FEBS Lett 1998;439:231-234.
56. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA: Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 1998;18:8126-8132.
57. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR: Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int J Geriatr Psychiatry 1998;13:840-845.